Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Technology and Equipment

A Smarter – and Synthetic – Workflow for Bioengineering

Researchers at Japan’s Kobe University have developed an integrated synthetic biology system that supports a more environmentally friendly approach to the synthesis of raw pharmaceutical products within microbes. Using a Design, Build, Test, Learn (DBTL) workflow (a pipeline for the discovery and optimization of biosynthetic pathways), the team constructed novel metabolic pathways and enzymes within cells that could be systematically optimized for the production of larger volumes of pharmaceutically relevant compounds (1). 

The project was carried out in collaboration with NEDO, a Japanese organization that funds many green research projects focusing on energy and industrial development. The Kobe group is leading NEDO’s Smart Cell Project, with a goal of developing adaptable cell factories for the production of diverse industrial materials. Using biological systems to produce industrial chemicals is more sustainable when compared to traditional chemical processes, but the current range of possible bioproduction targets is limited by known enzyme functions. Their recent report shows that it is possible to engineer new enzyme functions that can expand production capabilities towards new types of valuable chemicals. 
 

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

  1. CJ Vavricka et al, “Mechanism-based tuning of insect 3,4-dihydroxyphenylacetaldehyde synthase for synthetic bioproduction of benzylisoquinoline alkaloids”, Nature Communications, 10:2015 (2019).

About the Author

Maryam Mahdi

Assistant Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register